- Page 1: XLI Congresso Società Italiana di
- Page 7 and 8: Sotto l’Alto Patronato della Pres
- Page 9 and 10: CONSIGLIO DIRETTIVO SIN Presidente
- Page 11 and 12: BREVE STORIA DI CATANIA Seconda cit
- Page 13: AZIENDE ESPOSITRICI 13 Allergan Pha
- Page 16 and 17: SABATO 23 OTTOBRE TEATRO “MASSIMO
- Page 18 and 19: 09.00 11.00 11.30 13.30 13.30 14.30
- Page 20 and 21: 24 O T T O B R E • A U D I T O R
- Page 22 and 23: 24 O T T O B R E • S A L A D E M
- Page 24 and 25: 24 O T T O B R E • S A L A A L C
- Page 26 and 27: 24 O T T O B R E • S A L A P I T
- Page 28 and 29: 24 O T T O B R E • S A L A F I L
- Page 30 and 31: 24 O T T O B R E • CASI CLINICI:
- Page 32 and 33: 24 O T T O B R E • CONFERENZA DID
- Page 34 and 35: 24 O T T O B R E • CONFERENZA DID
- Page 36 and 37: 24 O T T O B R E • SIMPOSIO ore 1
- Page 38 and 39: 24 O T T O B R E • S A L A A R C
- Page 40 and 41: 24 O T T O B R E • SIMPOSIO ore 1
- Page 42 and 43: 24 O T T O B R E • S A L A SIMPOS
- Page 44 and 45: 24 O T T O B R E • S A L A E M P
- Page 46 and 47: 24 O T T O B R E • S A L A F I L
- Page 48 and 49: 24 O T T O B R E • S A L A A L C
- Page 50 and 51: 24 O T T O B R E • S A L A P A U
- Page 52 and 53: 24 O T T O B R E • S A L A GRUPPO
- Page 54 and 55:
LUNEDI 25 OTTOBRE AUDITORIUM SALA E
- Page 56 and 57:
25 O T T O B R E • A U D I T O R
- Page 58 and 59:
25 O T T O B R E • S A L A D E M
- Page 60 and 61:
25 O T T O B R E • S A L A A C R
- Page 62 and 63:
25 O T T O B R E • S A L A A R C
- Page 64 and 65:
25 O T T O B R E • S A L A F I L
- Page 66 and 67:
25 O T T O B R E • CASI CLINICI I
- Page 68 and 69:
25 O T T O B R E • CONFERENZA DID
- Page 70 and 71:
25 O T T O B R E • S A L A CONFER
- Page 72 and 73:
25 O T T O B R E • S A L A F I L
- Page 74 and 75:
25 O T T O B R E • SIMPOSIO ore 1
- Page 76 and 77:
25 O T T O B R E • S A L A A L C
- Page 78 and 79:
25 O T T O B R E • SIMPOSIO ore 1
- Page 80 and 81:
25 O T T O B R E • GRUPPO DI STUD
- Page 82 and 83:
25 O T T O B R E • GRUPPO DI STUD
- Page 84 and 85:
25 O T T O B R E • S A L A ASSOCI
- Page 86 and 87:
25 O T T O B R E • S A L A P A U
- Page 88 and 89:
25 O T T O B R E • S A L A ASSOCI
- Page 90 and 91:
09.00 11.00 11.30 13.30 13.30 14.30
- Page 92 and 93:
26 O T T O B R E • A U D I T O R
- Page 94 and 95:
26 O T T O B R E • S A L A D E M
- Page 96 and 97:
26 O T T O B R E • S A L A A C R
- Page 98 and 99:
26 O T T O B R E • S A L A A R C
- Page 100 and 101:
26 O T T O B R E • S A L A P I T
- Page 102 and 103:
26 O T T O B R E • S A L A F I L
- Page 104 and 105:
26 O T T O B R E • CONFERENZA DID
- Page 106 and 107:
26 O T T O B R E • CONFERENZA DID
- Page 108 and 109:
26 O T T O B R E • CONFERENZA DID
- Page 110 and 111:
26 O T T O B R E • S A L A F I L
- Page 112 and 113:
26 O T T O B R E • CORSO ore 14.3
- Page 114 and 115:
26 O T T O B R E • SIMPOSIO ore 1
- Page 116 and 117:
26 O T T O B R E • S A L A P I T
- Page 118 and 119:
26 O T T O B R E • A U D I T O R
- Page 120 and 121:
8.30 10.30 11.30 13.30 AUDITORIUM S
- Page 122 and 123:
27 O T T O B R E • S A L A E M P
- Page 124 and 125:
27 O T T O B R E • S A L A F I L
- Page 126 and 127:
27 O T T O B R E • S A L A A L C
- Page 128 and 129:
27 O T T O B R E • S A L A P I T
- Page 130 and 131:
27 O T T O B R E • S A L A F I L
- Page 132 and 133:
27 O T T O B R E • S A L A E M P
- Page 134 and 135:
27 O T T O B R E • S A L A GRUPPO
- Page 136 and 137:
27 O T T O B R E • S A L A A L C
- Page 138 and 139:
27 O T T O B R E • GRUPPO DI STUD
- Page 140 and 141:
27 O T T O B R E • S A L A ASSOCI
- Page 142:
27 O T T O B R E • CHIUSURA DEI L
- Page 145 and 146:
11. BMAA EFFECTS ON SUBSTANTIA NIGR
- Page 147 and 148:
37. MARKERS OF LGG MALIGNANT DEGENE
- Page 149 and 150:
DEMENZA ED INVECCHIAMENTO 1 Moderat
- Page 151 and 152:
OF COMPLETE ATRIOVENTRICULAR BLOCK:
- Page 153 and 154:
110. EVALUATION OF BDNF GENE AS RIS
- Page 155 and 156:
133. THE CLINICAL PICTURE OF PERSIS
- Page 157 and 158:
158. A FAMILY AFFECTED BY PRIMARY F
- Page 159 and 160:
PERFORMANCE: AN IN VIVO FMRI INVEST
- Page 161 and 162:
210. SENSORIMOTOR RHYTHM-BASED BRAI
- Page 163 and 164:
CERAVOLO, S. ROSSI, D. MAFFEI, H. S
- Page 165 and 166:
252. MUTATIONAL ANALYSIS OF THE DCX
- Page 167 and 168:
L. MERICO, M. ACQUAVIVA, A. PANARO,
- Page 169 and 170:
298. DIAGNOSTIC CRITERIA FOR THE DI
- Page 171 and 172:
EPILESSIA 1 Moderatori V. SOFIA (Ca
- Page 173 and 174:
348. FUNCTIONING AND DISABILITY IN
- Page 175 and 176:
MALATTIE DEL MOTONEURONE Moderatori
- Page 177 and 178:
397. FUS GENE ANALYSIS IN AN ITALIA
- Page 179 and 180:
420. INCREASE OF RECENTLY-RELEASED
- Page 181 and 182:
POSTER ore 16.30 - 17.30 DISORDINI
- Page 183 and 184:
459. AMYGDALAR LOCAL STRUCTURAL DIF
- Page 185 and 186:
M. VALERIANI, S. TARANTINO, C. VOLL
- Page 187 and 188:
HEMOGLOBIN SATURATION IN MILD COGNI
- Page 189 and 190:
M. PRONTERA, M. ELIA, G. BOERO, G.
- Page 191 and 192:
F. PESCINI, F. CESARI, B. GIUSTI, J
- Page 193 and 194:
S. VIDALE, C. DE PIAZZA, L. SACCO,
- Page 195 and 196:
603. EARLY MOOD DEPRESSION IN SEVER
- Page 197 and 198:
IN MULTIPLE SCLEROSIS PATIENTS WITH
- Page 199 and 200:
651. INTRACELLULAR OXIDATIVE ACTIVI
- Page 201 and 202:
POSTER ore 10.30 - 11.30 DISORDINI
- Page 203 and 204:
NEUROIMMUNOLOGIA Moderatori P. ANNU
- Page 205 and 206:
709. WHITE MATTER ARCHITECTURE AND
- Page 207 and 208:
732. FUNCTIONAL NEUROIMAGING CORREL
- Page 209 and 210:
NEUROSCIENZE DI BASE Moderatori D.
- Page 211 and 212:
785. LAMBERT-EATON MYASTENIC SYNDRO
- Page 213 and 214:
809. BK CHANNEL BETA4 SUBUNIT GENE
- Page 215 and 216:
830. RANDOMIZED PLACEBO-CONTROLLED
- Page 217 and 218:
854. FATIGUE IN MULTIPLE SCLEROSIS
- Page 219 and 220:
878. HEALTH PROFESSIONALS’ PERSPE
- Page 221 and 222:
pagnatori o gli eventuali interessa
- Page 223 and 224:
ECM ● ISTRUZIONI Al Vostro arrivo
- Page 225 and 226:
In particolare, dei 150 crediti del
- Page 227 and 228:
MEDA PHARMA SPA MERCK SERONO SPA MI
- Page 229 and 230:
Catania Centro Congressuale Le Cimi
- Page 231 and 232:
Catania Centro Congressuale Le Cimi
- Page 236:
SEGRETERIA ORGANIZZATIVA SIN Studio